超性心肌病的双胞胎现象:报告的一系列病例
Jiang-Ting Zeng1, Ying-Ai Zhang2, Tian-Yi Ma1
1Department of Cardiology, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Hainan, China.
Anatolian journal of cardiology
|October 31, 2024
概括
双胞胎的高性心肌病 (HCM) 提供了对影响这种心脏病的遗传和环境因素的见解. 研究同卵双胞胎有助于了解疾病的变异性,并改进对高伤心肌病的个性化治疗方法.
科学领域:
- 心血管遗传学 心血管遗传学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 人类遗传学 人类遗传学
背景情况:
- 增高性心肌病变 (HCM) 是一种常见的遗传性心血管疾病.
- HCM涉及左心室壁的不对称加厚.
- 在受影响的家庭中,遗传倾向是常见的.
研究的目的:
- 对HCM双胞胎病例的全球临床研究进行审查和分析.
- 探索导致HCM的遗传和表观遗传因素.
- 突出基因查在HCM诊断和管理中的作用.
主要方法:
- 全球临床研究的系统审查,重点关注HCM双胞胎病例.
- 对HCM遗传基础和表观遗传影响的分析.
- 检查基因相同个体中的表型异质性.
主要成果:
- 双胞胎研究揭示了HCM中复杂的遗传和环境相互作用.
- 即使在基因相同的HCM病例中,表型变异性也存在.
- 遗传查对于HCM的早期和差异性诊断至关重要.
结论:
- 双胞胎数据增强了对HCM复杂基因架构的理解.
- 来自HCM双胞胎的见解可以导致个性化的管理策略.
- 对HCM双胞胎现象的进一步研究是有必要的,以改善患者的治疗结果.
相关概念视频
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...


